JAIDS Journal of Acquired Immune Deficiency Syndromes
译名:获得性免疫缺陷综合征杂志
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
1-3
2026
影响因子区间
—
平台估算
1%
2025
中国作者发文占比
USD 3,290
收费
期刊简介:JAIDS: Journal of Acquired Immune Deficiency Syndromes seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide.JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
【译文】JAIDS:获得性免疫缺陷综合征杂志致力于通过展示所有学科领域的重要新科学,来结束HIV疫情,这些科学有助于我们了解全球范围内HIV感染的生物学、治疗和预防。JAIDS:获得性免疫缺陷综合征杂志是HIV和AIDS相关信息的可靠、跨学科资源,重点关注基础和转化科学、临床科学、流行病学和预防。由临床病毒学、分子生物学和流行病学领域的顶尖领导者共同编辑,JAIDS发表了关于HIV感染诊断和治疗进展的重要信息,以及治疗和疫苗方法的最新研究。这本开创性的杂志汇集了严格同行评审的文章、当前研究的综述、临床试验结果和全球流行病学报告。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |